SpectraCure Valuation

Is SPEC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SPEC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SPEC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SPEC's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SPEC?

Key metric: As SPEC barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for SPEC. This is calculated by dividing SPEC's market cap by their current book value.
What is SPEC's PB Ratio?
PB Ratio	1.4x
Book	SEK 111.50m
Market Cap	SEK 159.88m

SPEC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	89.3x
Enterprise Value/EBITDA	-5.9x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does SPEC's PB Ratio compare to its peers?

The above table shows the PB ratio for SPEC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	3.9x
QLINEA Q-linea	5.1x	47.9%	SEK 129.7m
NEOLA Neola Medical	2.8x	n/a	SEK 203.4m
NOSA Nosa Plugs	6.8x	87.0%	SEK 127.2m
ICO Iconovo	0.7x	80.9%	SEK 80.5m
SPEC SpectraCure	1.4x	n/a	SEK 159.9m

Price-To-Book vs Peers: SPEC is good value based on its Price-To-Book Ratio (1.4x) compared to the peer average (3.9x).

Price to Book Ratio vs Industry

How does SPEC's PB Ratio compare vs other companies in the SE Medical Equipment Industry?

5 Companies	Price / Book	Estimated Growth	Market Cap
MEDF Medfield Diagnostics	0.3x	n/a	US$2.17m
BRIG Brighter	0.1x	n/a	US$2.23m
CALMA B Calmark Sweden	0.3x	n/a	US$1.08m
S2M S2Medical	0.2x	n/a	US$221.28k

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: SPEC is good value based on its Price-To-Book Ratio (1.4x) compared to the Swedish Medical Equipment industry average (2.3x).

Price to Book Ratio vs Fair Ratio

What is SPEC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SPEC PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	1.4x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate SPEC's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Iconovo

SEK 79.9m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.06

2.4%

-45.1%

Dignitana

SEK 96.7m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.19

3.5%

-45.9%

Mentice

SEK 536.9m

Provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

MNTC

SEK 21.90

2.8%

-46.6%